Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides

By Hioe C.E.   Qiu H.   Chend P.-D.   Bian Z.   Ming-Lie L.   Li J.   Singh M.   Kuebler P.   McGee P.   O'Hagan D.   Zamb T.   Koff W.   Allsopp C.   Chang Y.W.   Nixon D.F.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 412-418

Elsevier

Access to resources Recommend Favorite

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

By Lipford G.B.   Bauer S.   Wagner H.   Heeg K.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 313-320

Elsevier

Access to resources Recommend Favorite

Induction of systemic immune responses to measles virus synthetic peptides administered intranasally

By Hathaway L.J.   Partidos C.D.   Vohra P.   Steward M.W.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1495-1500

Elsevier

Access to resources Recommend Favorite

Recombinant BCG strains expressing the SIV mac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice

By Winter N.   Lagranderie M.   Gangloff S.   Leclerc C.   Gheorghiu M.   Gicquel B.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?

By Siegrist C.-A.   Saddallah F.   Tougne C.   Martinez X.   Kovarik J.   Lambert P.-H.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1473-1478

Elsevier

Access to resources Recommend Favorite